TWO SIGMA ADVISERS, LP - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 73 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2023$31,510
-82.0%
13,700
-78.7%
0.00%
Q2 2022$175,000
-75.1%
64,400
-72.7%
0.00%
-100.0%
Q1 2022$704,000
-47.4%
236,200
-31.4%
0.00%
-33.3%
Q4 2021$1,339,000
+169.4%
344,300
+197.3%
0.00%
+200.0%
Q3 2021$497,000
-27.0%
115,800
-48.4%
0.00%
-50.0%
Q2 2021$681,000
-51.5%
224,600
-46.7%
0.00%
-50.0%
Q1 2021$1,403,000
+1770.7%
421,200
+1647.7%
0.00%
Q3 2020$75,000
-75.2%
24,100
-85.5%
0.00%
-100.0%
Q2 2020$303,000
+124.4%
166,700
+24.4%
0.00%0.0%
Q1 2020$135,000
-40.0%
134,000
+65.4%
0.00%0.0%
Q4 2019$225,000
+86.0%
81,000
+2.1%
0.00%
Q3 2019$121,000
-32.8%
79,300
-8.2%
0.00%
Q2 2019$180,000
+41.7%
86,400
+142.7%
0.00%
Q1 2019$127,000
+101.6%
35,600
+117.1%
0.00%
Q4 2018$63,000
-52.6%
16,400
+16.3%
0.00%
Q3 2018$133,00014,1000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 3,705,128$10,300,0004.44%
RTW INVESTMENTS, LP 5,666,754$15,754,0000.59%
COWEN AND COMPANY, LLC 926,200$2,575,0000.22%
Hudson Bay Capital Management LP 850,000$2,363,0000.05%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,774,915$4,934,0000.03%
Point72 Asset Management, L.P. 1,897,284$5,274,0000.03%
683 Capital Management, LLC 77,368$215,0000.02%
Secure Asset Management, LLC 10,000$28,0000.02%
Qube Research & Technologies Ltd 166,138$462,0000.01%
Verition Fund Management LLC 174,455$485,0000.01%
View complete list of ARBUTUS BIOPHARMA CORP shareholders